Phocaeicola vulgatus-dominated gut community type

There is 1 paper on Phocaeicola vulgatus-dominated gut community type in aging research: 1 trial in people. The newest story, Nov 3, 2026: “Hormone therapy responses varied with women’s microbiomes”.

Biomarker

1 paper studies it1 finding

1 new paper in 30 daysSee all 1 papers on Phocaeicola vulgatus-dominated gut community type

“Phocaeicola vulgatus-dominated women exhibited greater hormonal responsiveness, superior clinical outcomes and were more likely to achieve 4-week rapid clinical remission than Prevotella copri-dominated women.”
Heterogeneity of microbiome responses to menopausal hormone therapy among perimenopausal womenNature medicine2026doi:10.1038/s41591-026-04737-4
  • Human trial1

Associations

1

4-week rapid clinical remission

upin humans1

1 study
  1. Phocaeicola vulgatus-dominated gut community type predicts 4-week rapid clinical remission in humans.

    “Phocaeicola vulgatus-dominated women exhibited greater hormonal responsiveness, superior clinical outcomes and were more likely to achieve 4-week rapid clinical remission than Prevotella copri-dominated women.”

    Human trialPhocaeicola vulgatus-dominated versus Prevotella copri-dominated baseline gut communities during menopausal hormone therapy4 weeksfemales

    Hormone therapy responses varied with women’s microbiomes

    Nature medicine

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 11 paper in 12 months
Nature Medicine

Hormone therapy responses varied with women’s microbiomes

In a six-month trial of 356 perimenopausal women, starting vaginal and gut microbial communities were linked to differences in hormone therapy responses.In a six-month trial of 356 perimenopausal women, starting vaginal and gut microbial communities were linked to differences in hormone therapy responses.

Cohort · 327 peopleGut and microbiome